IN-Vitro Diagnostics: Next Generation Point-of-Care Testing

IN-Vitro Diagnostics: Next Generation Point-of-Care Testing

Marcel Van Kasteel, CEO Handheld Diagnostics and CEO Biocell A/S, Philips BG Emerging Businesses

Marcel Van Kasteel, CEO Handheld Diagnostics and CEO Biocell A/S, Philips BG Emerging Businesses

With budgets shrinking healthcare providers are under greater pressure than ever to deliver value, optimizing procedures and providing cost-and time-efficient care. Point-of-care testing can support this— equipping healthcare professionals with the information they need to make smart, on-the-spot medical decisions that improve workflow efficiency and, ultimately, patient outcomes.

As a leader in health technology, our goal at Philips is to revolutionize healthcare management. Where currently diagnostic blood testing is often carried out in a laboratory setting, we’re innovating to move beyond these walls and bring it near the patient— wherever they need it.

In 2016, we took our first step toward achieving this goal, launching the Minicare I-20 handheld system with cardiac troponin-l (cTnI) assay for suspected heart attack, delivering lab comparable results within just 10 minutes. Now we have reached another important milestone with the launch of additional next generation Minicare in-vitro diagnostics systems:

• The Minicare C-300*—a clinical chemistry system that enables physicians to bypass the often time-consuming process of sending blood samples to a central or external laboratory for an extensive range of 27 chemistry parameters

• The Minicare H-300*—a hemostasis system that aids in the diagnosis and monitoring of coagulation abnormalities, giving the physicians crucial information in real time in critical care settings such as heavy blood trauma or massive surgery

• Minicare BNP*, an additional cardiac assay for the Minicare I-20, measuring the BNP (Brain Natriuretic Peptide) concentration in blood, to aid in the diagnosis of heart failure providing lab comparable test results within 10 minutes

By providing advanced clinical information through meaningful, cost-efficient and connected solutions, Philips is advancing toward our ultimate aim: to bring integrated and personalized care close to the patient, across the entire continuum of care.

With these advanced technologies and easy to use systems, Philips is helping to supply care providers with all the information they need to make decisions in the moments that matter, supporting them to streamline the patient journey and ensure that each individual gets the care they need.

Weekly Brief

Read Also

Delivering Improved Care to the Elderly Population

Delivering Improved Care to the Elderly Population

Sergey Gribov, Partner at Flint Capital
How the Medical Field Can Navigate Fire and Life Safety Better in 2022

How the Medical Field Can Navigate Fire and Life Safety Better in 2022

Bruce Falke, Director of Sales at CommercialFire
Artificial Intelligence in Healthcare- the Holy Grail or a Flash in the Pan?

Artificial Intelligence in Healthcare- the Holy Grail or a Flash in...

Shelly Nash, DO, FACOOG, ABPM-CI, Senior Vice President, Chief Medical Information Officer, Fresenius Medical Care, North America
How Full-Risk Capitation Facilitates Innovative Primary Care

How Full-Risk Capitation Facilitates Innovative Primary Care

Daniel Guerra, Associate Chief Medical Information Officer at ChenMed
Leading by Collaboration

Leading by Collaboration

Ashish Atreja, MD MPH, Chief Digital Health Officer, UC Davis Health Keisuke Nakagawa, MD, Director of Innovation, Digital CoLab, UC Davis Health
Extending the Reach of Health Care Beyond Its Borders Through Telehealth

Extending the Reach of Health Care Beyond Its Borders Through...

BenjaminH. Seo, Director, Global Business Development, Cedars-Sinai Medical Center Heitham T. Hassoun, MD, Vice President & Medical Director, International, Cedars-Sinai Medical Center